[Signalling mechanisms of cardioprotective effect of hypothermic preconditioning]

Area of Science:

• Cardiology
• Cellular Physiology
• Biochemistry

Background:

• Ischemia-reperfusion injury (IRI) is a major cause of heart damage.
• Preconditioning strategies aim to protect the heart against IRI.
• Hypothermic preconditioning (HP) is a potential cardioprotective method.

Purpose of the Study:

• To investigate the cardioprotective effects of HP against IRI.
• To compare the efficacy of HP with ischemic preconditioning (IP).
• To elucidate the molecular mechanisms underlying HP-induced cardioprotection.

Main Methods:

• Assessment of cardiomyocyte necrosis following IRI.
• Evaluation of cardiac pump function during reperfusion.
• Analysis of antiarrhythmic effects.
• Investigation of signaling pathways including adrenergic receptors, cAMP, protein kinases (PKA, PKC, AMPK), and mitochondrial permeability transition pore (mPTP).

Main Results:

• HP significantly prevented cardiomyocyte necrosis and improved cardiac pump function during reperfusion.
• HP demonstrated a more pronounced cardioprotective effect than IP.
• HP-mediated protection involved β-adrenergic receptor stimulation, increased cAMP, activation of PKA, PKC, AMPK, and mPTP blockade.
• HP did not affect the phosphorylation of GSK-3β and Akt-kinase.
• Reactive oxygen species and endogenous catecholamines were identified as triggers/mediators of HP.

Conclusions:

• Hypothermic preconditioning offers robust cardioprotection against IRI, superior to ischemic preconditioning.
• The protective effects of HP are mediated by a complex interplay of signaling pathways, including adrenergic stimulation, cAMP/PKA/PKC activation, and mPTP modulation.
• ROS and catecholamines play crucial roles in mediating HP's beneficial effects.